REDWOOD CITY, Calif., Feb. 21, 2014 (GLOBE NEWSWIRE) -- California based myoscience, inc., developers of the iovera°® system for the treatment of peripheral nerve conditions, announced today that Clint Carnell, Chairman and Chief Executive Officer, will present at the Cowen and Company 34th Annual Health Care Conference in Boston, MA. Carnell will present on Wednesday, March 5, 2014 at 10:30 am ET.
ABOUT MYOSCIENCE
Silicon Valley, California-based myoscience is a privately-held medical device company committed to making its platform technology, Focused Cold Therapy, the standard of care for the treatment of peripheral nerve conditions. Focused Cold Therapy is the patented technology delivered by the iovera° system. The iovera° system is currently approved in Europe and Canada for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions, and is indicated in the United States for use in pain management and general surgical use. For more information, please visit www.myoscience.com.
The myoscience logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13581
© 2014 myoscience. All rights reserved. iovera° and Focused Cold Therapy are trademarks of myoscience.